The pro-inflammatory signalling regulator Stat4 promotes vasculogenesis of great vessels derived from endothelial

Zhao-Zheng Meng1, Wei Liu1, Yu Xia1

  • 1Key Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences &Shanghai Jiao Tong University School of Medicine, Shanghai 200031, China.

Nature Communications
|March 4, 2017
PubMed

Insights

Stat4 promotes great vessel development in zebrafish by regulating endothelial precursors. Its deficiency causes pharyngeal arch artery defects, suggesting Stat4 as a potential therapeutic target for congenital cardiovascular diseases.

Area of Science:

  • Developmental biology
  • Genetics
  • Cardiovascular research

Background:

  • Congenital cardiovascular diseases often stem from defects in great vessel (GV) formation.
  • Genetic regulators of endothelial precursors during GV vasculogenesis are not well understood.

Purpose of the Study:

  • To investigate the role of Stat4 in zebrafish GV vasculogenesis.
  • To identify genetic regulators of endothelial precursors in GV development.

Main Methods:

  • Utilized zebrafish models to study gene function in vivo.
  • Analyzed gene expression patterns using transcript enrichment.
  • Investigated gene ablation effects on vascular development.
  • Examined gene regulatory networks involving Stat4, nkx2.5, hdac3, and stat1a.

Main Results:

  • Stat4 transcripts are enriched in nkx2.5+ endothelial precursors in the pharynx.
  • Genetic ablation of stat4 leads to pharyngeal arch artery (PAA) stenosis by impairing angioblast development.
  • Stat4 acts downstream of nkx2.5 and promotes endothelial precursor proliferation.
  • Stat4 inhibits hdac3 expression and counteracts stat1a activity in PAA angioblasts.

Conclusions:

  • Stat4 is crucial for zebrafish great vessel development.
  • Stat4 regulates endothelial precursor proliferation and differentiation.
  • Stat4 may represent a therapeutic target for great vessel defects and congenital heart disease.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K
Development of Blood Vessels01:07

Development of Blood Vessels

The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
1.6K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.3K